Deze webcast is Engelstalig en oorspronkelijk bedoeld voor Belgische hematologen en dermatologen. Aanmelding voor deze webcast vind daarom plaats op https://www.springermedicine.com/ctcl3.
Cutaneous T-Cell Lymphoma (CTCL) is a chronic and progressive malignancy that can have a profound impact on patients’ quality of life, long-term outcomes and survival. Early recognition of disease progression is therefore essential to optimize treatment outcomes and prevent unnecessary disease burden.
In this accredited webcast, leading experts Professor Nikkels, Professor Leeman, and Dr. Saevels will share the latest insights, real-world evidence, and practical patient cases to support clinical decision-making in patients with progressing CTCL.
Target group
This webcast is primarily intended for:
- Belgian Dermatologists
- Belgian Hematologists
Other interested healthcare professionals with prescribing authority are also welcome to register.
Accreditation
An application will be made to the UEMS EACCME for CME/CPD for this event.
Date
13 October 2026, 20:00 – 21:30 (CEST)
Available free of charge
This webcast is offered to you free of charge.
Questions
If you have any questions about this webcast broadcast, please contact nascholing@springer.com.
Powered by:
KKI/BNL/POT/0222 – September 2026
-
Privacy Statement
In accordance with the GDPR, Springer complies with all applicable laws and regulations governing the processing of personal data. For this continuing medical education programme, Springer and Kyowa Kirin collaborate while each independently determines the purposes and means of processing personal data. Springer and Kyowa Kirin therefore act as separate data controllers. The applicable privacy statements can be found here: Springer Healthcare & Kyowa Kirin.
This broadcast is made possible in part by Springer Medicine.
-
www.springermedicine.com/
Springer Medicine is operationally managed by Springer Medizin Verlag as a joint initiative of the medical brands within the Springer Nature Group. In addition to Springer Medizin, the Springer Nature Health Group includes premium brands such as Springer Healthcare, MedNet, and Bohn Stafleu van Loghum (BSL). Springer Medicine is also the new home of Springer Healthcare’s specialist information platform, “Medicine Matters.”